The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 18, 2025

Filed:

May. 25, 2020
Applicants:

Rigshospitalet, Copenhagen Ø, DK;

Københavns Universitet, Copenhagen Ø, DK;

Inventors:

Andreas Kjær, Copenhagen Ø, DK;

Matthias Manfred Herth, Copenhagen Ø, DK;

Elsa Johanna Louise Steen, Copenhagen Ø, DK;

Jesper Tranekær Jørgensen, Copenhagen Ø, DK;

Hannes Mikula, Vienna, AT;

Christoph Denk, Vienna, AT;

Assignees:

Rigshospitalet, Copenhagen Ø, DK;

Københavns Universitet, Copenhagen Ø, DK;

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 51/04 (2006.01); A61P 35/00 (2006.01); C07D 257/08 (2006.01); C07D 401/04 (2006.01);
U.S. Cl.
CPC ...
A61K 51/0455 (2013.01); A61K 51/044 (2013.01); A61K 51/0491 (2013.01); A61P 35/00 (2018.01); C07D 257/08 (2013.01); C07D 401/04 (2013.01); C07B 2200/05 (2013.01);
Abstract

NovelF-labelled tetrazines are provided which are highly reactive to be effective in vivo, suitable for pretargeted positron emission tomography (PET) and accessible in radiochemical yields (RCYs) which allow access toF-labeled tetrazines for clinical applications. TheF-labelled tetrazines are developed using a Cu-mediated click indirect labelling approach. Only a subset of compounds appeared to be suitable for clinical pretargeted imaging strategies, and a particular compound which includes the use of anF-labelled azide synthon having an azide structure with glucose as the linker and a triazole moiety within the linker, appears to be highly suited for clinical pretargeted imaging purposes.


Find Patent Forward Citations

Loading…